These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ. Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [Abstract] [Full Text] [Related]
6. The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice. Lee DW, Leinung MC, Grasso P. Regul Pept; 2008 Oct 09; 150(1-3):62-5. PubMed ID: 18455249 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery. Dow J, Dulery BD, Hornsperger JM, Di Francesco GF, Keshary P, Haegele KD. Arzneimittelforschung; 1995 Dec 09; 45(12):1245-52. PubMed ID: 8595078 [Abstract] [Full Text] [Related]
11. Analytical determination and pharmacokinetics of robenacoxib in the dog. Jung M, Lees P, Seewald W, King JN. J Vet Pharmacol Ther; 2009 Feb 09; 32(1):41-8. PubMed ID: 19161454 [Abstract] [Full Text] [Related]
12. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis. Cook JJ, Gardell SJ, Holahan MA, Sitko GR, Stump GL, Wallace AA, Gilberto DB, Hare TR, Krueger JA, Dyer DL, Sanderson PE, Vacca JP, Shafer JA, Lynch JJ. J Pharmacol Exp Ther; 1999 Apr 09; 289(1):503-10. PubMed ID: 10087043 [Abstract] [Full Text] [Related]
17. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2. Zhang Y, Hua Y, Benbrook DM, Covey JM, Dai G, Liu Z, Chan KK. Cancer Chemother Pharmacol; 2006 Nov 09; 58(5):561-9. PubMed ID: 16534614 [Abstract] [Full Text] [Related]
18. Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy. Tucker TJ, Lumma WC, Lewis SD, Gardell SJ, Lucas BJ, Baskin EP, Woltmann R, Lynch JJ, Lyle EA, Appleby SD, Chen IW, Dancheck KB, Vacca JP. J Med Chem; 1997 May 23; 40(11):1565-9. PubMed ID: 9171866 [Abstract] [Full Text] [Related]
20. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs. Kukanich B, Lascelles BD, Aman AM, Mealey KL, Papich MG. J Vet Pharmacol Ther; 2005 Oct 23; 28(5):461-6. PubMed ID: 16207309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]